Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest emphysema Stories

2010-06-01 01:00:00

HORSHAM, Pa., June 1 /PRNewswire/ -- Centocor Ortho Biotech Inc. today announced that it has acquired RespiVert Ltd., a privately held drug discovery company focused on developing small-molecule, inhaled therapies for the treatment of pulmonary diseases. The company's lead compounds, RV-568 and RV-1088, narrow spectrum kinase inhibitors with a unique profile of anti-inflammatory activities, are progressing into clinical development as potential first-in-class treatments for moderate to...

2010-05-17 08:00:00

FREMONT, Calif., May 17 /PRNewswire/ -- Quark Pharmaceuticals, Inc., the world leader in clinical development of RNAi-based therapeutics, announced today the publication of new insights on the role of its proprietary gene target, RTP801, in cigarette smoke-induced pulmonary injury and emphysema. Results are published in the June 2010 edition of Nature Medicine and online in a paper titled "RTP801, a suppressor of mammalian targets of rapamycin (mTOR) signaling, is an essential mediator of...

c92aa1237849fe5adbcdfb16a2180528
2010-04-06 12:04:35

CT scans can detect differences in lung blood flow patterns, which identify smokers most at risk of emphysema Using CT scans to measure blood flow in the lungs of people who smoke may offer a way to identify which smokers are most at risk of emphysema before the disease damages and eventually destroys areas of the lungs, according to a University of Iowa study. The study found that smokers who have very subtle signs of emphysema, but still have normal lung function, have very different blood...

2010-03-18 12:33:08

Researchers in Australia have demonstrated that blocking a certain protein can reduce or prevent cigarette smoke-induced lung inflammation in mice. Inflammation underlies the disease process of chronic obstructive pulmonary disease (COPD) and many other smoking-related ailments. The findings have been published online ahead of print publication in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine. Cigarette smoking causes lung inflammation, which can...

2010-02-19 08:14:00

SILVER SPRING, Md., Feb. 19 /PRNewswire/ --The Pulmonary Hypertension Association (PHA) announced today that three pulmonary hypertension (PH) specialists began their eight-day "Path to a Cure" journey to the 19,341-foot summit of Mt. Kilimanjaro to raise global awareness of PH, a disease that affects the heart and lungs. Raymond Benza, M.D., Robert Frantz, M.D., and Jessica Lazar, MPA, PA-C, are climbing Africa's highest peak in an effort to bring attention to this rare and serious...

2010-02-18 08:30:00

RIDGEFIELD, Conn., Feb. 18 /PRNewswire/ -- Hollywood, sports and music stars brought the public along for the ride as they raced 6,000 miles in four days to find the millions of people who may be at risk for Chronic Obstructive Pulmonary Disease (COPD), which kills one person every four minutes. Through Twitter, Facebook, Flickr and YouTube, tens of thousands of people followed the celebrities as they traveled to 14 cities to screen thousands of people for this relatively unknown top...

2010-02-03 06:30:00

RIDGEFIELD, Conn., Feb. 3 /PRNewswire/ -- A powerful group of entertainment, sports and healthcare organizations and celebrities have joined forces to screen millions of people who may be at risk for Chronic Obstructive Pulmonary Disease (COPD), the nation's fourth leading cause of death. The American Lung Association, Boehringer Ingelheim Pharmaceuticals, Inc., COPD Foundation and NASCAR® today kicked off DRIVE4COPD, a multi-year public health initiative aiming to reach...

2010-01-27 09:45:59

Possible drug targets identified to alleviate critical symptoms associated with emphysema Chronic obstructive pulmonary disease (COPD) is defined by emphysema and/or chronic bronchitis. It destroys the normal architecture of the lung and inhibits the mechanical aspects of breathing, which prevents necessary gas exchange. Patients suffer from coughing fits, wheezing, and increased incidence of lung infections. These symptoms are associated with changes in the architecture of the lung. The air...

2010-01-21 07:00:00

SAN DIEGO, Jan. 21 /PRNewswire/ -- Elevation Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of new aerosol therapies for patients with respiratory diseases, announced today the closing of a $30 million tranched Series A financing. Investors participating include Canaan Partners, TPG Growth, Care Capital, and Mesa Verde Venture Partners. Concurrent with this financing, Elevation has added to its board of directors Brent Ahrens, General Partner at Canaan,...

2010-01-20 18:25:17

Sponsored by the NHLBI, study shows that COPD, even when mild, limits heart function A new study from Columbia University Medical Center researchers, has found that the heart's ability to pump effectively is diminished among people with a common lung disease, even in people with no or mild symptoms. Published in the Jan. 21, 2010 issue of the New England Journal of Medicine, the research is the first to show a strong link between heart function and mild COPD (chronic obstructive pulmonary...


Latest emphysema Reference Libraries

Lung
2013-01-01 15:53:59

The lung is a vital organ that is a part of the respiratory system. Generally a person has two lungs; however, the body can function with only one. The lung’s main function is to move oxygen and carbon dioxide into and out of the bloodstream through gas exchange. The lungs are located lateral to the heart in the thoracic cavity. Each lung has a tip called the apex, which is superior in the body. The bases of the lungs rest on the diaphragm. They appear to be spongy due to their bundles of...

More Articles (1 articles) »